Patents by Inventor Dana Carmel Hammel

Dana Carmel Hammel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
    Publication number: 20090156814
    Abstract: Described herein are opioid prodrugs, methods of making opioid prodrugs, formulations comprising opioid prodrugs, and methods of using opioid prodrugs. One embodiment described herein relates to the transdermal administration of a buprenorphine prodrug in an abuse-resistant formulation for treating and preventing diseases and/or disorders.
    Type: Application
    Filed: February 19, 2009
    Publication date: June 18, 2009
    Applicant: AllTranz Inc.
    Inventors: Audra Lynn Stinchcomb, Miroslaw Jerzy Golinski, Dana Carmel Hammel, Jeffrey Lynn Howard
  • PRODRUGS OF CANNABIDIOL, COMPOSITIONS COMPRISING PRODRUGS OF CANNABIDIOL AND METHODS OF USING THE SAME
    Publication number: 20090036523
    Abstract: Described herein are cannabidiol prodrugs, methods of making cannabidiol prodrugs, formulations comprising cannabidiol prodrugs and methods of using cannabidiols. One embodiment described herein relates to the transdermal or topical administration of a cannabidiol prodrug for treating and preventing diseases and/or disorders.
    Type: Application
    Filed: July 30, 2008
    Publication date: February 5, 2009
    Applicant: AllTranz Inc.
    Inventors: Audra Lynn Stinchcomb, Miroslaw Jerzy Golinski, Dana Carmel Hammel, Jeffery Lynn Howard, Stan Lee Banks
  • Use of cannabidiol prodrugs in pharmaceutical compositions
    Patent number: RE47885
    Abstract: Described herein are cannabidiol prodrugs used in pharmaceutical compositions as well as microneedle drug delivery systems comprising a pharmaceutical compositions comprising pharmaceutically active agents (e.g., cannabidiol and prodrugs of cannabidiol) and microneedle arrays suitable for local and systemic delivery of the active agent to a mammal. Also described herein are methods of using a microneedle transdermal or topical drug delivery systems comprising pharmaceutical compositions, comprising cannabidiol and prodrugs of cannabidiol, and microneedle arrays in the treatment disease, including pancreatitis and pancreatic cancer.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: March 3, 2020
    Assignee: Zynerba Pharmaceuticals, Inc.
    Inventors: Audra Lynn Strinchcomb, Stan Lee Banks, Miroslaw Jerzy Golinski, Jeffrey Lynn Howard, Dana Carmel Hammel